Side-Effects
of
Chemotherapy Intervention
The side-effects of chemotherapy drugs are generally
categorized in the medical studies as follows, according to their ‘site
of action’:
1. DIGESTIVE UPSETS (NAUSEA, VOMITING, ANOREXIA,
STOMATITIS, DIARRHOEA, ETC.):
SCHEIN, P.S., MACDONALS, J.S., WATERS, C., HAIDAK,D., Nutritional
complications of cancer and its treatment, Semin. Oncol., Dec. 1975; 2
(4): 337-347; DREIZEN, S., Stomatotoxic manifestations of cancer chemotherapy,
J. Prosthet. Dent., Dec. 1978; HYSON, E.A., BURRELL, M., TOFFLER,
R., Drug-induced gastro intestinal disease, Gastrointest. Radiol., 20
Dec. 1977; 2 (3): 183-212; OHNOMA, T., HOLLAND, J.F., Nutritional consequences
of cancer chemotherapy and immunotherapy, Cancer Res., July 1977, 37 (7
Pt 2): 2395-2406; N.N., Cancer chemotherapy the inbuilt deterrent, Br.
Med. J., 24 Nov. 1979; 2 (6201): 1312-1313; SCHUM, C.A., IZUTSU, K.T.,
MOLBO, D.M., TRUELOVE, E.L., GALLUCCI,B., Changes in salivary buffer capacity
in patients undergoing cancer chemotherapy, J. Oral. Med., Jul-Sept.,
1979; 34 (3): 76-80; SCOGNA, D.M., SMALLEY, R.V., Chemotherapy-induced
nausea and vomiting, Am J. Nurs., Sept. 1979; 79 (9): 1562-1564; KENNEDY,
M., PACKARD, R., GRANT, M.M., PADILLA, G.V., Chemotherapy related nausea
and vomiting: a survey to identify problems and interventions, Oncol.
Nurs. Forum, Winter 1981; 8 (1): 19-22.
2. AFFECTIONS OF THE SKIN AND MUCUOUS MEMBRANE (ALL SORTS OF AFFECTIONS,
NAIL DAMAGE, ALOPECIA, ETC.):
NIXON, D.W, Alterations in nail pigment with cancer chemotherapy,
Arch. Intern. Med., Oct. 1976; 136 (10): 1117-1118; DREIZEN, S., BODEY,
G.P., RODRIGUEZ, V., McCREDIE, K.B., Cutaneous complications of cancer
chemotherapy, Postgrad. Med., Nov. 1975; 58 (6): 150-158; BARAN, R., Pigmentation
of the nail (chromonynchia), J. Dermatol. Surg. Oncol., Mar. 1978; 4 (3):
250-254; GAUCI, L., SERROU, B., Changes in hair pigmentation associated
with cancer chemotherapy, Cancer Treat. Rep., Jan. 1980; 64 (1): 193.
3. HAEMATOPOIETIC ALTERATION (IMMUNO-DEPRESSION, BLOOD
COMPOSITION ALTERATION, ETC.):
JEDRZEJCZAK, W.W., SIEKIERZYNSKI, M., CZARNECKI, C., DZIUK,
E., Patterns of changes in peripheral blood composition in the course
of combination chemotherapy of cancer, Strahlentherapie, Nov. 1976; 152
(5): 469-476; BODEY G.P., RODRIGUEZ, V., McCREDIE, K.B., FREIREICH, E.J.,
Neutropenia and infection following cancer chemotherapy, Int. J. Radiat.
Oncol. Biol. Phys., Jan. - Feb. 1976; 1 (3-4): 301-304; VAN DER HOEVEN,
L., CHANG, J.C., Disorders of granulocytes induced by toxic agents, Ann.
Clin. Lab. Sci., Sept. - Oct. 1976; 6 (5): 415-422; TATTERSHALL, M.H.,
Aggressive cancer treatment and its role in predisposing to infection,
Eur. J. Cancer, Aug. 1975; 11 Suppl.: 9-19; RENOUX, M., BERNARD, J.F.,
TORRES, M., SCHLEGEL, N., AMAR, M., LOPEZ, M., BOIVIN, P., Erythrocyte
abnormalities induced by chemotherapy and radiotherapy: induction of pre
leukaemic state., Scand. J. Hematol., Oct. 1978; 21 (4): 323-332; FERRARO,
E.F., Implications of anti neoplastic therapy, Dent. Surv., Febr. 1978;
54 (2): 32-33; MASON, B.A., KLUG, P.P., COHEN, P., Bone marrow necrosis
during chemotherapy for lymphoma, J.A.M.A., 20 Mar. 1978; 239 (12): 1158;
BADHURI, S., RASHE, H., KÖHLE, W., DIETRICH, M., Blutgerinnungsstudien
bei Patienten mit akuter Leukämie vor und nach zytostatischer Chemotherapie,
Verh. Dtsch. Ges. Inn. Med., 17-21 Apr. 1977; 83: 1142-1144; KAKISHITA,
E., YOSHIMURA, S., Influence of anti cancer chemotherapy on haemostatic
mechanism (Japanese), Rinsho Byori, Dec. 1977, 25 (12): 985-991; NERI,
A., BRUGIATELLI, M., COMIS, M., IACOB, P., NOBILE, F., PACIUCCI, P.A.,
LOMBARDO, V.T., Severe acute hyperkalaemia following chemotherapy, Haematologica
(Pavia), Jun. 197 ***; 62 (3): 331-332; KREPLER, P., Infections in children
with malignant disease, Wien. Klin. Wochenschr., 9 Nov. 1979; 91 (21):
707-71 *** ; RYBALBA, A.M., Prevention and treatment of haemapoietic disorders
during the chemotherapy of malignant ovarian tumours (Ukranian), Pedriatr.
Akush. Ginekol., Sept. - Oct. 1979; (5): 45-46; ETIEMBLE, J., BERNARD,
J.F., PICAT, C., BELPOMME, D., BOIVIN, P., Red blood cell enzyme abnormalities
in patients treated with chemotherapy, Br. J. Haematol., Jul. 1979; 42
(3): 391-398: HAROUSSEAU, J.L., TOBELEM, G., SCHAISON, G., JACQUILLAT,
C., Leucémies aigues lymphoblastiques hyperleucocytaires: problèmes
d’urgence au cours du traitement initial, Nouv. Presse Méd., 19
May 1979; 8 (22): 1827-1830; LY, B., SOLHEIM, B.G., SKAR, A.G., Granulocytopenia
and infections during induction therapy of acute leukaemia (Norwegian),
Tidsskr. Nor. Laegeforen, Febr. 1981; 101 (6): 379-386.
4. AFFECTION OF THE REPRODUCTIVE ORGANS (STERILITY, IMPOTENCE,
AZOOSPERMIA, AMENORRHEA, GYNECOMASTIA, ETC.):
RUSSEL, J.A., POWLES, R.L., OLIVER, R.T., Conception and
congenital abnormalities after chemotherapy of acute myelogenous leukaemia
in two men, Br. Med. J., 19 Jun. 1976; 1 (6024): 1508; SIRIS, E.S., LEVENTHAL,
B.G., VAITUKAITIS, J.L., Effects of childhood leukaemia and chemotherapy
on puberty and reproductive function in girls, N. Engl. J. Med., 20 May
1976; 294 (21): 1143-1146; ASBJORNSEN, G., MOLNE, K., KLEPP, O., AAKVAAG,
A., Testicular function after combination chemotherapy for Hodgkin’s disease,
Scand. J. Haematol., Jan. 1976; 16 (1): 66-69; DI LIBERTI, J.H., Teratogenesis
and chemotherapy, Ann. Intern. Med., Nov. 1974; 81 (5): 709; SUTCLIFFE,
S.B., Cytotoxex chemotherapy and gonadal function in patients with Hodgkin’s
disease, J.A.M.A., 26 Oct. 1979; 242 (17): 1898-1899; CHAPMAN, R.M., SUTCLIFFE,
S.B., MALPAS, J.S., Cytotoxic-induced ovarian failure in Hodgkin’s disease.
Effects on sexual function, J.A.M.A., 26 Oct. 1979; 242 (17): 1882-1884;
GLASS, A.R., BERENBERG, J., Gynecomastia after chemotherapy for lymphoma,
Arch. Intern. Med., Sept. 1979; 139 (9): 1048-1049; RUSTIN, G.J., BAGSHAWE,
K.D., NEWLANDS, E.S., BEGENT, R.H., Cytotoxic drugs and sterility, Lancet,
13 Jun. 1981; 1 (8233): 1316; THORNELDE, W.F., Cytotoxic-induced ovarian
failure in Hodgkin’s disease, J.A.M.A., 1 Aug. 1980; 244 (5): 435.
5. RENAL AND LIVER DAMAGE:
JAYABOSE, S., SHENDE, A., LANZKOWSKY, P., Hepatotoxicity
of chemotherapy following nephrectomy and radiation therapy for right-sided
Willms tumour, J. Pediatr., May 1976; 88 (5): 898; KANFER, A., ROLAND,
J., CHATELET, F., RICHET, G., Insuffisance rénale aigue hyperphosphatémique
au cours d’un lymphosarcome, J. Urol. Nephrol., (Paris), Apr. - May 1979;
85 (4-5): 337.
6. IMPAIRMENT OF THE OSSEOUS (SKELETAL) SYSTEM:
IHDE, D.C., DEVITA, V.T., Osteonecrosis of the femoral
head in patients with lymphoma treated with intermittent combination chemotherapy,
Cancer, Nov. 1975; 36 (5): 1585-1588.
7. PULMONARY DISEASES:
KÜHBÖCK, S., Lungenfibrosen nach Behandlung mit
Zytostatika, Wien. Med. Wochenschr., 1 Oct. 1976; 126 (40): 568-570; CAUBARRERE,
I., Les pneumopathies infectueuses au cours de la chimiothérapie
des hémopathies malignes, Rev. Prat., 21 May 1976; 26 (29): 2051-2060;
SIZOD, W., WOLVIUS, G.G., Pneumocystis-pneumonie als complicatie bij cytostatische
therapie, Nederl. Tijdschr. Geneeskunde, 6 Mar. 1976; 120 (10): 418-424;
SAUER, E., GULLOTTA, U., FINK, U., Akute beidseitige Lungeninfiltration
als Komplikation der Zytostatischen Therapie, Dtsch. Med. Wochenschr.,
10 Oct. 1975; 100 (41): 2098-2101; OKITA, H., ITO, K., TAKETOMI, Y., FUJIMURA,
K., KURAMOTO, A., Four patients with leukaemia who showed especially a
typical type of interstitial pneumonia, probably caused following the
administration of anti-leukaemic drugs (Japanese), Jpn. J. Clin. Hematol.,
30 Jul. 1974; 15 (7): 764-773; HERMANSKY, F., BENESOVA, E., CHMEL, J.,
JIRAK, A., Pulmonary complications caused by cytostatic treatment (Czech),
Vnitr. Lek., Jun. 1977; 23 (7): 695-701; DEMETER, S.L., AHAMD, M., TOMASHEKSKI,
J.F., Drug-induced pulmonary disease, Cleve. Clin. Q., Fall 1979; 46 (3):
113-124; ZHU, G.Y., Acute pulmonary edema during chemotherapy of late
stage tumors (Chinese), Chung Hua Chieh Ho Ho Hu Hsi Hsi Chi Ping Tsa
Chih, Dec. 1980; 3 (4): 201-202.
8. MUTAGENIC (CANCER-CAUSING) CHANGES:
MAJSKY, A., JAKOUBKOVA, J., ABRAHAMOVA, J., Chemotherapy
one of the causes of transient loss of HLA antigens and lymphocyte poly-reactivity
in patients with blood diseases and malignancies, J. Immunogenet., Dec.
1976; 3 (6): 429-433; ROSS, G.T., Congenital anomalies among children
born of mothers receiving chemotherapy for gestational trophoblastic neoplasms,
Cancer, Feb. 1976; 37 (2 Suppl.): 1043-1047; POLEKSIC, S., YEUNG, K.Y.,
Rapid development of keratoancanthoma and accelerated transformation into
squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy
in a patient with Hodgkin’s disease, Cancer, Jan. 1978; 41 (1): 12-16;
SCHAISON, G., JACQUILLAT, C., AUCLERC, G., WEIL, M., Les risques foeto-embryonnaires
des chimiothérapies, Bull. Cancer (Paris), 1979; 66 (2): 165-170;
SAKALOVA, A., BENKO, J., IZAKOVIC, V., Anti tumorous therapy and its consequences
upon gravidity and foetus (Slovakian), Cesk. Gynekol., May 1979; 44 (4):
272-276; SCHADER, A.I., Teratogenic effects of anti leukaemia chemotherapy,
Arch. Intern. Med., Mar. 1981; 141 (4): 514-515; KAEMPFER, S.H., The effects
of cancer chemotherapy on reproduction: a review of the literature, Oncol.
Nurs. Forum, Winter 1981; 8 (1): 11-18.
9. CANCER-PRODUCING SIDE-EFFECTS:
HAQUE, T., LUTCHER, C., FAGUET, G., TALLEDI, O., Chemotherapy-associated
acute myelogenous leukaemia and ovarian carcinoma, Am. J. Med. Sci., Sept.
- Oct. 1976; 272 (2): 225-228; JOCHIMSEN, P.R., PEARLMAN, N.W., LAWTON,
R.L., Pancreatic carcinoma as a sequel to therapy of lymphoma, J. Surg.
Oncol., 1976; 8 (6): 461-464; SEIDENFELD, A.M., SMYTHE, H.A., OGRYZLO,
M.A., UROWITZ, M.B., DOTTEN, D.A., Acute leukaemia in rheumatoid arthritis
treated with cytotoxic agents, J. Rheumatol., Sept. 1976; 3 (3): 295-304;
ROBERTS, M.M., Acute leukaemia after immunosuppressive therapy, Lancet,
9 Oct. 1976; 2 (7989): 768-770; KUIS, W., DE KRAKER, J., KUIJTEN, R.H.,
DONCKERWOLCKE, R.A., VOUTE, P.A., Acute lymphoblastic leukaemia after
treatment of nephrotic syndrome with immunosuppressive drugs, Helv. Paediatr.
Acta, Jun. 1976; 31 (1): 91-95; NAESS, K., Cancer of the pancreas chemically
induced. Can drugs play a role? (Norwegian), Tidsskr. Nor. Laegeforen,
10 Jun. 1976; 96(16): 949; STECHMILLER, B., WIERNIK, P.H., SHIN, M., SATTERFIELD,
J., Metastatic teratocarcinoma following chemotherapy. Maturation to a
mass pathologically indistinguishable from a mediastinal enteric cyst,
Chest, May 1976; 69 (5): 697-700; JAFFE, N., Late side-effects of treatment:
skeletal, genetic, central nervous system and oncogenic, Pediatr. Clin.
N. Am., Feb. 1976; 23 (1): 233-244; MEADOWS, A.T., D’ANGIO, G.J., EVANS,
A.E., HARRIS, C.C., MILLER, R.W., MIKE, V., Oncogenesis and other late
effects of cancer treatment in children, Radiology, Jan. 1975; 114 (1):
175-180; SCHWARZ, J.H., CANELLOS, G.P., YOUNG, R.C., DEVITA, V.T. Jr.,
Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia,
Am. J. Med., Dec. 1975, 59 (6): 819-829; TERRACINI, B., Il ruolo di alcuni
farmaci nell’ezioologia dei tumori delle vie urinarie, Cancro, 1973; 26
(3): 185-188; LI, F.P., CASSADY, J.R., JAFFE, N., Risk of second tumours
in survivors of childhood cancer, Cancer, Apr. 1975: 35 (4): 1230-1235;
CARTER, S.K., Second tumours complicating cancer therapy, Haematol. Bluttransfus.,
1978; 22: 41-44; BOIVIN, P., Les leucémies induites par la radiothérapie
ou par la chimiothérapie peuvent-elles êtres prévues?
Nouv. Presse Méd., 9 Sept. 1979; 7 (29): 2533-2534; LEGLER, F.,
Karzinogenese durch Schadstoffe aus der Umwelt, Pharmaka und Ernährungsgewohnheiten,
Oeff. Gesundheitswes., Oct. 1978; 40 (10): 653-662; SCHULER, D., Iatrogenic
carcinogenesis (Hungarian), Orv. Hetil., 10 Sept. 1978; 119 (37): 2239-2243;
ROSNER, F., Is chemotherapy carcinogenic?, Cancer, Jan. Feb. 1978; 28
(1): 57-59; PENN, I., Malignancies associated with immunosuppressive or
cytotoxic therapy, Surgery, May 1978; 83 (5): 492-502; NIEWEG, H.O., Iatrogene
leukaemie, Nederl. Tijdschr. Geneesk., 25 Mar. 1978; 122 (12): 398-401;
MULDER, N.H., HOUWEN, B., Behandelen en vooruitzien. Acute leukaemie na
behandeling van een andere kwaadaardige ziekte, Nederl. Tijdschr. Geneesk.,
25 Mar. 1978; 122 (12): 385-399; ERSKINE, J.G., WANG, I., HUTTON, M.M.,
Chronic granulocytic leukemia developing upon a follicular lymphoma, Br.
Med. J., 19 Nov. 1977; 2 (6098): 1329; CADMAN, E.C., CAPIZZI, R.L., BERTINO,
J.R., Acute non-lymphocytic leukaemia: a delayed complication of Hodgkin’s
disease therapy: analysis of 109 cases, Cancer, Sept. 1977; 40 (3): 1280-1296;
CHABNER, B.A., Second neoplasm a complication of cancer chemotherapy,
N. Engl. J. Med., 28 Jul. 1977, 297 (4): 213-215; KURTIDES, E.S., Breast
cancer, chemotherapy and second malignant neoplasms, J.A.M.A., 4 Jul.
1977; 238 (1): 28-29; WOLF, M.M., COOPER, I.A., DING, J.C., Hodgkin’s
disease terminating in acute leukaemia: a report of seven cases, Austr.
N. Z. J. Med., Aug. 1979; 9 (4): 398-402; KAHN, M.F., ARLET, J., BLOCH-MICHEL,
H., CAROIT, M., CHAOUAT, Y., RENIER, J.C., Leucémies aigues après
traitement par agents cytotoxiques en rhumatologie. 19 observations chez
2006 patients, Nouv. Presse Méd., 14 Apr. 1979; 8 (17): 1393-1397;
PENN, I., Leukaemias and lymphomas associated with the use of cytotoxic
and immunosuppressive drugs, Cancer Res., 1979; 69: 7-13; JOUET, J.P.,HUART,
J.J., BAUTERS, F., GOUDEMAND, M., Leucémies aigues complicant la
maladie de Hodgkin. Cinq nouvelles observations, Nouv. Presse Méd.,
17 Feb. 1979; 8 (8): 613-614; DANO, K., FORCHHAMMER, J., Carcinogenesis
and drugs (Danish), Ugeskr. Laeger., Aug. 1981; 143 (35): 2246-2247; FARBER,
E., Chemical carcinogenesis, N. Engl. J. Med., 3 Dec. 1981; 305 (23):
1379-1389; STEWART, A.L., WILKINSON, P.M., Rapid onset of acute myeloid
leukaemia following radiotherapy and chemotherapy for metastatic seminoma
of the testis, J. Cancer Res. Clin. Oncol., 1981; 100 (1): 109-111; HOOVER,
R., FRAUMENI, J.F., Jr., Drug-induced cancer, Cancer, 1 Mar. 1981; 47
(5 Suppl.): 1071-1080; BLANC, A.P., GASTAUT, J.A., SEBAHOUN, G., DALIVOUST,
P., MURISASCO, A., CARCASSONNE, Y., Naissance d’une leucémie aigue
au décours d’un traitement immunosupprésseur par le chlorambucil.
Une observation, Nouv. Presse Méd., May 1981; 10 (21): 1717-1719;
CORDIER, J.F., TOURAINE, R., Cancers épidermoides du poumon chez
un patient traité pour cancer aplasique à petites cellules.
La chimiothérapie favorise-t-elle le développement de cancers
d’un autre type histologique?, Nouv. Presse Méd., 9 May 1981; 10
(21): 1713-1716; ASBORNSEN, G., GODAL, H.C., MYHRE, K., Acute myelogenous
leukaemia after cytostatic therapy in breast cancer (Norwegian), Tidsskr.
Nor. Laegeforen, Feb. 1981; 101 (6): 387-388; PENN, I. Immunosuppression
and skin cancer, Clin. Plast. Surg., Jul. 1980, 7 (3): 361-368; CHAN,
K.W., MILLER, D.R., TAN, C.T., Osteosarcoma and acute myeloblastic leukaemia
after therapy for childhood Hodgkin’s disease - a case report, Med. Pediatr.
Oncol., 1980; 8 (2): 143-149; MAHOMED, Y., MANDEL, M.A., CRAMER, S.F.,
MICHEL, B., Squamous cell carcinoma arising in pemphigus vulgaris during
immunosuppressive therapy, Cancer, 15 Sept. 1980; 46 (6): 1374-1377; DOHY,
H., GENOT, J.Y., IMBERT, M., D’AGAY, M.F., SULTAN, C., Myelodysplasia
and leukaemia related to chemotherapy and/or radiotherapy: a haematological
study of 13 cases. Value of macrocytosis as an early sign of bone marrow
injury, Clin. Lab. Haematol., 1980, 2 (2): 111-119.
10. IMPAIRMENT OF THE CENTRAL NERVOUS SYSTEM:
SHERKOW, L.H., Chemotherapeutic neurotoxicity on brain
scintigraphy, Clin. Nucl. Med., Oct. 1979; 4 (10): 439-440.
11. CARDIOTOXICITY:
KAYE, S.B., IKRAM, H., Acute cardiac pain and electrocardiographic
changes following cytotoxic treatment for metastatic carcinoma, Clin.
Oncol., Sept. 1976; 2 (3): 215-218; WEINSTEIN, P., GREENWALD, E.S., GROSSMAN,
J., Unusual cardiac reaction to chemotherapy following mediastinal irradiation
in a patient with Hodgkin’s disease, Am. J. Med., Jan. 1976; 60 (1): 152-156;
APPELBAUM, F., STRAUCHEN, J.A., GRAW, R.G. Jr., SAVAGE, D.D., KENT, K.M.,
FERRANS, V.J., HERZIG, G.P., Acute lethal carditis caused by high-dose
combination chemotherapy. A unique clinical and pathological entity, Lancet,
10 Jan. 1976; 1 (7950): 58-62; GHIONE, M., Effetti tossici dei farmaci
antitumorali sul sistema cardiovascolare, Recent Prog. Med. (Roma), Oct.
1977; 63 (4): 382-410; SZABO, G., KOVACS, A., Intra-arterial chemotherapy
of head and neck tumours, Acta Chir. Acad. Sci. Hung., 1979; 20 (1): 49-55;
GARIMOLDI, M., PIAZZA, E., BERTELLO, C., RUGGERI, P.R., LIBRETTI, A.,
Effetto della chemioterapia antiblastica su alcuni parametri cardiologice,
Boll. Soc. Ital. Cardiol., 1978; 23 (10): 1785-1790.
12. MISCELLANEA:
Hansen SW; Helweg-Larsen S; Trojaborg W, Long-term neurotoxicity
in patients treated with cisplatin, vinblastine, and bleomycin for
metastatic germ cell cancer, J Clin Oncol (UNITED STATES)
Oct 1989 7 (10) p1457-61;Eifel PJ; McClure S , Severe chemotherapy-induced
recall of radiation mucositis in a patient with non-Hodgkin’s lymphoma
of Waldeyer’s ring [letter], Int J Radiat Oncol Biol Phys Oct 1989
17 (4) p907-8; Tsatsoulis A; Shalet SM; Robertson WR; Morris ID;
Burger HG; De Kretser DM, Plasma inhibin levels in men with chemotherapy-induced
severe damage to the seminiferous epithelium., Clin Endocrinol (Oxf)
(ENGLAND) Dec 1988 29 (6) p659-65; Ocular complications after intracarotid
BCNU for intracranial tumors, Acta Ophthalmol (Copenh) Feb 1989
67 (1) p83-6; Gerasimova MM; Bogoslovskaia IA; Karcharova SV; Litovskaia
AV, Professional diseases caused by the action of antibiotics, Vrach
Delo (USSR) May 1989 (5) p109-12; Cartei G; Ceschia
T; Marsilio P; Clocchiatti L; Fasola G; Morandini G; Galletti D;
Sibau A, Effectiveness and toxicity of “BELD” polychemotherapy in
advanced malignant melanoma, Tumori (ITALY) Jun 30 1989
75 (3) p229-32; Mansi ML , Clear cell renal carcinoma in a pregnant DES-exposed
patient, J Am Osteopath Assoc (UNITED STATES) Jul 1989 89 (7) p929-32;
Williams F, Diethylstilboestrol exposure and testicular cancer [letter],
Int J Epidemiol (ENGLAND) Jun 1989 18 (2) p462-3
ISSN: 0300-5771 Language: ENGLISH; Bressollette L; Swirsky
H; Kernaleguen D; Carlhant D; Fauquert P; Le Bot MA; Baccino E;
Riche C, Hepatitis during treatment with tamoxifen. Effects on the
kinetics of epirubicin (letter), Therapie (FRANCE) Mar-Apr
1989 44 (2) p151-2 ; Meneghello A; Presacco D; Di Maggio C, Aseptic
osteonecrosis of the femoral head in cancer patients with neuropathies
caused by vincristine and vinblastine] Complesso Clinico
Ospedaliero, Padova. Radiol Med (Torino) (ITALY)
Jun 1989 77 (6) p626-30; Grasela TH Jr; Walawander CA;
Welage LS; Wing PE; Scarafoni DJ; Caldwell JW; Noguchi JK; Schentag
JJ , Prospective surveillance of antibiotic-associated coagulopathy in
970 patients, Pharmacotherapy 1989 9 (3) p258-64; Rubin
B; Palestine AG, Complications of corticosteroid and immunosuppressive
drugs, Int Ophthalmol Clin (UNITED STATES) Fall 1989 29 (3)
p159-71 ; Peiffert D; Bey P; Lederlin P; Conroy T; Witz F
, Immediate hematological toxicity during combination chemotherapy- radiotherapy
of Hodgkin’s disease, Bull Cancer (Paris) 1989 76 (4) p373-82;
Szende B; Schally AV; Srkalovic G; Comaru-Schally AM; Wittliff JL , Adverse
effect of tamoxifen with LHRH agonist on oestrogen-receptor-negative
mammary carcinoma [letter] , Lancet (ENGLAND) Jul 22 1989
2 (8656) p222-3; Matsuura T; Nakabayashi H; Yanagisawa T; Yamazaki K;
Watanabe R; Kameda H; Sakata A , Primary malignant lymphoma
of the brain following immunosuppressive therapy of systemic lupus
erythematosus, Nippon Naika Gakkai Zasshi (JAPAN) May 1987
76 (5) p730-5 ; Metzler M , Metabolism of some anabolic agents:
toxicological and analytical aspects, J Chromatogr (NETHERLANDS)
Apr 7 1989 489 (1) p11-21; Hirvonen HE; Salmi TT; Heinonen
E; Antila KJ; Valimaki IA , Vincristine treatment of acute lymphoblastic
leukaemia induces transient autonomic cardioneuropathy, Cancer
Aug 15 1989 64 (4) p801-5; Wilkinson H , Dangers from methylprednisolone
acetate therapy by intraspinal injection [letter], Arch Neurol
(UNITED STATES) Jul 1989 46 (7) p721-2; Hillbertz-Nilsson
K; Forsberg JG , Genotoxic effects of estrogens in epithelial
cells from the neonatal mouse uterine cervix: modifications by metabolic
modifiers, Teratogenesis Carcinog Mutagen (UNITED STATES)
1989 9 (2) p97-110; Gendron Y; Bronstein JA; Gras C; Boz P,
Neuromuscular toxicity of colchicine. A case (letter)], Presse Med
Jun 24 1989 18 (25) p1256; Hansen SW; Olsen N
, Raynaud’s phenomenon in patients treated with cisplatin, vinblastine,
and bleomycin for germ cell cancer: measurement of vasoconstrictor
response to cold, J Clin Oncol (UNITED STATES) Jul 1989
7 (7) p940-2; Boudouris O; Ferrand S; Guillet JL; Madelenat
P , Paradoxical effects of tamoxifen on the woman’s uterus, J Gynecol
Obstet Biol Reprod (Paris) (FRANCE) 1989 18 (3) p372-8;
Fillastre JP, Drug nephrotoxicity: mechanisms of action] Nephrotoxicite
medicamenteuse: mecanismes d’action, Ann Biol Clin (Paris) 1989
47 (2) p91-7; Wortsman J; Hamidinia A; Winters SJ, Hypogonadism following
long-term treatment with diethylstilbestrol, Am J Med Sci (UNITED
STATES) Jun 1989 297 (6) p365-8; Mironova IN; Batov SV; Aldylbaev
TA, Mental disorders during chemotherapy of malignant testicular
neoplasms, Zh Nevropatol Psikhiatr (USSR) 1989 89 (2)
p87-90; Wingard DL; Turiel J , Long-term effects of exposure to diethylstilbestrol,
West J Med (UNITED STATES) Nov 1988 149 (5) p551-4;
N.N., Ophthalmologic complications of low-dose tamoxifen in the treatment
of breast carcinoma (letter), Ned Tijdschr Geneeskd (NETHERLANDS)
Apr 29 1989 133 (17) p903-4 ; Wiest PM; Flanigan T; Salata
RA; Shlaes DM; Katzman M; Lederman MM , Serious infectious complications
of corticosteroid therapy for COPD, Chest (UNITED STATES)
Jun 1989 95 (6) p1180-4 ; Vyborov AM; Romanenko GF , Kaposi’s
sarcoma in a female patient taking corticosteroids for a long time, Vestn
Dermatol Venerol (USSR) 1989 (1) p48-9 ; Fujii
H; Yashige H; Maekawa T; Horiike S, Acute myeloid leukemia six years after
chemotherapy of Hodgkin’s disease] , Rinsho Ketsueki (JAPAN)
Dec 1988 29 (12) p2369-74; Beyer BK; Greenaway JC; Fantel AG; Juchau
MR , Embryotoxicity induced by diethylstilbestrol in vitro, J Biochem
Toxicol Summer 1987 2 p77-92 ; Love RR , Tamoxifen
therapy in primary breast cancer: biology, efficacy, and side effects,
J Clin Oncol (UNITED STATES) Jun 1989 7 (6) p803-15
; von Muhlendahl KE; Bramswig J; Traupe H; Happle R, Acne fulminans
following high-dose testosterone treatment in tall boys, Dtsch Med Wochenschr
(GERMANY, WEST) May 5 1989 114 (18) p712-4 ; Lagler
U; Gattiker HH , Acute dyspnea following intravenous administration of
vinblastine/mitomycin C, Schweiz Med Wochenschr (SWITZERLAND)
Mar 4 1989 119 (9) p290-2 ; de Jong-Busnac M , Ophthalmologic complications
of low-dosage tamoxifen in the treatment of breast carcinoma, Ned
Tijdschr Geneeskd (NETHERLANDS) Mar 11 1989 133 (10)
p514-6 Peterson GM; McGinty JF, Direct neurotoxic effects
of colchicine on cholinergic neurons in medial septum and striatum,
Neurosci Lett Nov 22 1988 94 (1-2) p46-51; Luciani I , Fatal
i.v. colchicine injection in a 60-year-old woman, JEN Mar-Apr 1989
15 (2( Pt 1)) p80-2; Zeymer U; Neuhaus KL , Infarct-typical changes in
the electrocardiogram following chemotherapy with vinblastine, Dtsch
Med Wochenschr (GERMANY, WEST) Apr 14 1989 114 (15)
p589-92 ; Lamartiniere CA; Pardo GA , Altered activation/detoxication
enzymology following neonatal diethylstilbestrol treatment., J Biochem
Toxicol Summer 1988 3 p87-103; Saxena AK; Nigam PK,
Panniculitis following steroid therapy, Cutis Oct 1988 42
(4) p341-2; Ochs J; Mulhern RK , Late effects of antileukemic treatment,
Pediatr Clin North Am Aug 1988 35 (4) p815-33 ;
LeBaron S; Zeltzer LK; LeBaron C; Scott SE; Zeltzer PM , Chemotherapy
side-effects in pediatric oncology patients: drugs, age, and sex as risk
factors, Med Pediatr Oncol 1988 16 (4) p263-8 ;
Satou M; Koshikawa S , Drug-induced glomerulonephritis, Nippon Rinsho
(JAPAN) Jun 1988 46 (6) p1413-8 ; Gonadal activity and chemotherapy-induced
gonadal damage [letter], JAMA (UNITED STATES) Oct 14 1988
260 (14) p2064-6; Gradishar WJ; Schilsky RL , Effects of cancer
treatment on the reproductive system, CRC Crit Rev Oncol Hematol
(UNITED STATES) 1988 8 (2) p153-71; Brok KE; Elberg
JJ , Teratogenic effect of thiotepa despite observation of safety regulations,
Ugeskr Laeger (DENMARK) Aug 1 1988 150 (31) p1898-9;
Brinch L; Evensen SA; Stavem P; Svare A, Neurological problems in
leukemia, Tidsskr Nor Laegeforen (NORWAY) Aug 10 1988
108 (22) p1587-9; Ries F, Nephrotoxicity of chemotherapy,
Eur J Cancer Clin Oncol (ENGLAND) Jun 1988 24 (6) p951-3
; Drings P , Late cardio respiratory sequelae following chemo- and
radiotherapy, Med Klin (GERMANY, WEST) May 27 1988 83
(12) p408-16; Smith MA; Shah NR; Lobel JS; Cera PJ; Gary GW; Anderson
LJ, Severe anaemia caused by human parvovirus in a leukaemia patient
on maintenance chemotherapy, Clin Pediatr (Phila) Aug 1988
27 (8) p383-6; Kusumoto M; Nagata M; Seguchi U , Nursing of
a leukaemic patient with severe nausea and vomiting caused by chemotherapy,
Kango Gijutsu (JAPAN) Jun 1988 34 (8) p926-30; Bookman MA;
Longo DL; Young RC , Late complications of curative treatment in Hodgkin’s
disease [clinical conference, JAMA (UNITED STATES) Aug 5 1988
260 (5) p680-3; Scrobohaci ML; Drouet L; Baudin B , Hemostasis tests as
markers of hepatic and endothelial toxicity in chemotherapy, Nouv Rev
Fr Hematol (GERMANY, WEST) 1988 30 (1-2) p109-14; Kaldor
JM; Day NE; Hemminki K, Quantifying the carcinogenicity of anti
neoplastic drugs, Eur J Cancer Clin Oncol Apr 1988 24 (4)
p703-11; Frick SB; Guzzi DelPo E; Keith JA; Davis MS, Chemotherapy-associated
nausea and vomiting in pediatric oncology patients, Cancer Nurs
Apr 1988 11 (2) p118-24; Madsen ES; Larsen H , Excretion of mutagens
in sweat from humans treated with anti-neoplastic drugs, Cancer Lett
(IRELAND) Jun 15 1988 40 (2) p199-202 ; Colls BM , Cytotoxic
chemotherapy: a potential hazard to patients and hospital personnel?,
N Z Med J Mar 11 1987 100 (819) p149-50; Shaw PJ; Nightingale
WE; Bergin ME; Stevens MM, Use of silver sulphadiazine cream for
burns caused by cytotoxic-drug extravasation [letter], Med J Aust
(AUSTRALIA) Jun 20 1988 148 (12) p657; Inamatsu
T , Colonic diseases due to various therapeutic agents, Nippon Rinsho
(JAPAN) Feb 1988 46 (2) p451-6 ; Kamata H; Murakami
A; Miyagawa N; Yasui H; Nagano H; Abe S; Ueda K; Kisida S , A case of
leukoencephalopathy caused by HCFU, Gan No Rinsho May 1988
34 (6) p783-6 ; Tsai LT; Chang TT; Hwang KP; Chen TS, Clinical study
of interstitial pneumonia in acute lymphoblastic leukaemia children under
anti-cancer therapy, Kao Hsiung I Hsueh Ko Hsueh Tsa Chih Dec 1985
1 (12) p754-60; Krasowska I; Urban M , Non-hematological side-effects
of cytostatic drugs used in children, Pediatr Pol (POLAND)
Nov-Dec 1987 62 (11-12) p787-92 ; Kardos G; Gacs G; Solyom
J; Revesz T; Kajtar P; Koos R; Schuler R , Changes in gonadal function
after treatment of malignant diseases in children, Orv Hetil Mar
27 1988 129 (13) p657-8, 661-2 ; Andrykowski MA , Defining
anticipatory nausea and vomiting: differences among cancer chemotherapy
patients who report pretreatment nausea, J Behav Med (UNITED STATES)
Feb 1988 11 (1) p59-69; Umbach GE , Carcinoma of the
cervix: chemotherapy, toxicity, and survival [letter], J Clin Oncol
(UNITED STATES) May 1988 6 (5) p926-7; Propert KJ; Anderson
JR, Assessing the effect of toxicity on prognosis: methods of analysis
and interpretation, J Clin Oncol (UNITED STATES) May 1988
6 (5) p868-70; Nasu H; Inoue Y; Nakamura J; Iizuka M; Arakawa H; Masamune
O , A case of gastric cancer associated with hyperkalemia during the effective
chemotherapy, Nippon Gan Chiryo Gakkai Shi (JAPAN) Dec 20
1987 22 (10) p2347-51; van der Does-van den Berg A; Hahlen
K; de Vaan GA; Veerman AJ, Late sequelae of the treatment of children
with acute lymphatic leukaemia, Ned Tijdschr Geneeskd Mar 26 1988
132 (13) p568-71; Meadows AT , Risk factors for second malignant neoplasms:
report from the Late Effects Study Group, Bull Cancer (Paris) 1988
75 (1) p125-30; Hantel A; Rowinsky EK; Donehower RC , Nifedipine
and oncologic Raynaud phenomenon [letter], Ann Intern Med (UNITED
STATES) May 1988 108 (5) p767; Hoshino K; Mizushima
Y; Yano S; Kitagawa M , An autopsied case of pulmonary carcinoma with
perforation peritonitis due to metastatic tumor necrosis at the jejunum
caused by chemotherapy, Gan No Rinsho Apr 1988 34 (4) p491-6;
Rado J, Electrolyte disorders caused by drugs, Orv Hetil (HUNGARY)
Jan 3 1988 129 (1) p25-31; Henry-Amar M , Quantitative risk
of second cancer in patients in first complete remission from early stages
of Hodgkin’s disease, NCI Monogr (UNITED STATES) 1988
(6) p65-72; Mulder PO; Sleijfer DT; de Vries EG; Uges DR; Mulder
NH, Renal dysfunction following high-dose carboplatin treatment,
J Cancer Res Clin Oncol (GERMANY, WEST) 1988 114 (2)
p212-4; Martinez CL; Ciavaglia SJ; Costello PB , Adverse effects
of pharmacologic agents used in the treatment of rheumatic diseases, Ear
Nose Throat J (UNITED STATES) Nov 1987 66 (11) p463-6
; Balducci L; Phillips DM; Gearhart JG; Little DD; Bowie C;
McGehee RP , Sexual complications of cancer treatment, Am Fam Physician
(UNITED STATES) Mar 1988 37 (3) p159-72 ; Magnenat JL;
Junod AF, Pulmonary toxicity of drugs, Ther Umsch (SWITZERLAND)
Dec 1987 44 (12) p949-54; Ciambellotti E; Cartia GL; Coda C, Scintigraphy
of the bone marrow for the evaluation of injuries caused by antiblastic
agents, Radiol Med (Torino) (ITALY) Jan-Feb 1988 75
(1-2) p78-82 ; Najean Y , The iatrogenic leukaemias induced
by radio- and/or chemotherapy, Med Oncol Tumor Pharmacother (ENGLAND)
1987 4 (3-4) p245-57 ; Fraser MC; Tucker MA, Late effects
of cancer therapy: chemotherapy-related malignancies, Oncol Nurs Forum
(UNITED STATES) Jan-Feb 1988 15 (1) p67-77; Fillastre
JP; Viotte G; Morin JP; Moulin B, Nephrotoxicity of antitumoral agents,
Adv Nephrol (UNITED STATES) 1988 17 p175-218 ; Davis
HP; Newlands ES; Allain T; Hegde U , Immune thrombocytopenia caused by
flavone-8-acetic acid [letter], Lancet Feb 20 1988 1 (8582)
p412; Zetterberg G; Bjorkholm M; Eklund AE; Farnebo LO, Acute abdominal
symptoms in patients with granulocytopenia--a clinical dilemma, Lakartidningen
(SWEDEN) Dec 9 1987 84 (50) p4248-9; Ono J; Nohara T;
Nakase A, Effects of anticancer drugs on hepatic fibrosis in the
rats with carbon tetrachloride-induced hepatic injury, Nippon Gan Chiryo
Gakkai Shi (JAPAN) Jul 20 1987 22 (6) p1240-9; Talbot
GH; Provencher M; Cassileth PA, Persistent fever after recovery
from granulocytopenia in acute leukemia, Arch Intern Med Jan 1988
148 (1) p129-35; Rubin RH , Empiric antibacterial therapy in granulocytopenia
induced by cancer chemotherapy, Ann Intern Med (UNITED STATES)
Jan 1988 108 (1) p134-6; Ivlev AS; Polunina TE, Drug-induced
hepatitis during the hormonal treatment of patients with prostatic tumours,
Urol Nefrol (Mosk) (USSR) Sep-Oct 1987 (5) p65-6;
Kantarjian HM; Keating MJ, Therapy-related leukemia and myelodysplastic
syndrome, Semin Oncol (UNITED STATES) Dec 1987 14 (4)
p435-43; Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
, Risk of second cancers after treatment for Hodgkin’s disease, N Engl
J Med (UNITED STATES) Jan 14 1988 318 (2) p76-81;D’ARCY,
P.F., Iatrogenic didease: a hazard of multiple drug therapy, R. Soc. Health
J., Dec. 1976; 96 (6): 277-283; SEVEROVA, E.I., Main results and trends
in the study of side-effects of drugs (Russian), Soc. Med., Apr. 1976;
(4): 7-15; D’ANGIO, G.J., Cure has its tomorrows, Int. J. Radiat. Oncol.
Biol. Phys., Jan. - Feb. 1976; 1 (3-4): 373-374; ALMICI, C., CORDONI,
A., D’ADDA, P., INZOLI, M.R., LAZZARONI, G., ZAMBRUNI, A., Le malattie
secondarie indotte dalla chemiotherapia citostatica, G. Clin. Med., Mar.
- Apr. 1976; 56 (2): 131-143; KORDECKI, H., URASINKI, I., Side-effects
of polychemotherapy in patients with acute leukaemia (Polish), Pol. Tyg.
Lek., 7 Jun. 1976; 31 (23): 973-975; SCHEIN, P.S., WINOKUR, S.H., Immunosuppressive
and cytotoxic chemotherapy: long-term complications, Ann. Intern. Med.,
Jan. 1976; 82 (1): 84-95; MIHICH E., Immunosuppression in cancer therapeutics,
in MURPHY, G.P. (Ed.), Cancer and transplantation, N.Y., Grune & Strattn,
1975, p. 137-140; KLATERSKY, J., Les complications médicales de
la chimiothérapie, Acta Clin. Belg., 1975; 30 (6): 538-546; GÜRTLER,
R., The risk of adjuvant chemotherapy, Arch. Geschwulstforsch., 1978;
48 (7): 644-652; PETRANYI, G. Hazards of cytotoxic therapy (Hungarian),
Orv. Hetil., 8 Jan. 1978; 119 (2): 63-69; GEIB, K.R., PAPAZIAN, R., Therapeutic
progress and iatrogenic problems in malignant hemopathies (Rumanian),
Rev. Med. Intern., Jul. - Aug. 1977; 29 (4): 343-349; CREAVEN, P.J., MIHICH,
E., The clinical toxicity of anticancer drugs and its prediction, Semin.
Oncol., Jun. 1977; 4 (2): 147-163; GUTJAHR, P., JUNG, H., Spätfolgen
der Tumorbehandlung im Kindesalter, Laryngol. Rhinol. Otol. (Stuttgart),
Jun. 1977; 147-163; SCHÖNFELDER, M., Komplikationen nach Chemotherapie
solider maligner menschlicher Tumoren und deren Therapie, Zentralbl. Chir.,
1979; 104 (17): 1103-1110; DEMIN, A.A., SMIRNOV, V.V., Chemotherapy of
lymphogranulomatosis (Russian), Sov. Med., Aug. 1979; (8): 86-90; SPIEGEL,
R.J., MAGRATH, I.T., Tumor lysis pancreatitis, Med. Pediatr. Oncol., 1979;
7 (2): 169-172; METTLER, F.A. Jr., Manifestation of drug toxicity, Curr.
Probl. Diagn. Radiol., Jul. - Aug. 1979; 8 (4): 1-55; TULLY, J.L., LEW,
M.A., CONNOR, M., D’ORSI, C.J., Clostridial sepsis following hepatic arterial
infusion chemotherapy, Am. J. Med., Oct. 1979; 67 (4): 707-710; THOMSON,
L., Cancer chemotherapy: a guide for nurses. Side-effects of chemotherapy,
Nurs. Times, 19 Jul. 1979; 75 (29): Suppl. 5-8; HARRINGTON, W.J., Iatrogenic
disorders from cancer treatment, Adv. Intern. Med., 1979; 24: 141-155;
NINANE, J., Serious infections during continuing treatment of acute lymphoblastic
leukemia, Arch. Dis. Child., Nov. 1981; 56 (11): 841-844; DODD, M.J.,
DODD, D.W., Chemotherapy: helping patients to know the drugs they are
receiving and their possible side-effects, Cancer Nurs., Aug. 1981; 4
(4): 311-318; GLASS, A., WIESAND, H.S., FISCHER, B., REDMOND, C., LERNER,
H., WOLTER, J., SHIBATA, H., PLOTKIN, D., FOSTER, R., MARGOLESE, R., WOLMARK,
N., Acute toxicity during adjuvant chemotherapy for breast cancer: The
National Surgical Adjuvant Breast and Bowel Project (NSABP), experience
from 1717 patients receiving single and multiple agents, Cancer Treat.
Rep., May - Jun. 1981; 65 (5-6): 363-376; ZAJICEK, G., The risk of chemotherapy,
Med. Hypotheses, Mar. 1981; 7 (3): 363-372; RHOMBERG, W., Probleme der
kumulativen Toxizität von Radiotherapie und zytostatischer Chemotherapie
beim Bronchialkarzinom, Onkologie, Jun. 1980; 3 (3): 97-101; LEVITT, D.Z.,
Cancer chemotherapy: those dreaded side-effects and what to do about them,
R.N., Aug. 1980; 43 (8): 51-54, 55-60; GHIONE, M., Effetti collaterali
della chemioterapia antitumorale, Minerva Med., 14 Apr. 1980; 71 (15):
1095-1099; KAPADIA, S.B., KRAUSE, J.R., ELLIS, L.D., PAN, S.F., WALD,
N., Induced non-lymphocytic leukaemia following long-term chemotherapy:
a study of 20 cases, Cancer, 15 Mar. 1980; 45 (6): 1315-1321; MARKOE,
A.M., The effects of combined radiation and chemotherapy on the immune
response, Prog. Exp. Tumor Res., 25: 219-228.
